rhCollagen-based regenerative breast implants address $2.8 billion global breast implant market with revolutionary and potentially safer new product Regenerative breast implants for aesthetic and ...

Bio-printing technology now enables fabrication of 200cc implant size and above to address future commercial demand Interim pre-clinical data shows tissue growth including regeneration of maturing ...

- Further protection granted in key territory applying to the significant and growing aesthetic and reconstructive markets - This newly allowed patent application pertains to CollPlant's injectable ...

3D bioprinting holds great potential in the field of regenerative medicine to produce miniaturized tissues and organ precursors with biological functionality. Today, however, scientists are still ...